JP2018512876A5 - - Google Patents

Download PDF

Info

Publication number
JP2018512876A5
JP2018512876A5 JP2017555233A JP2017555233A JP2018512876A5 JP 2018512876 A5 JP2018512876 A5 JP 2018512876A5 JP 2017555233 A JP2017555233 A JP 2017555233A JP 2017555233 A JP2017555233 A JP 2017555233A JP 2018512876 A5 JP2018512876 A5 JP 2018512876A5
Authority
JP
Japan
Prior art keywords
sarna
antisense
group
strand
sense
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017555233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018512876A6 (ja
JP2018512876A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2016/051116 external-priority patent/WO2016170348A2/en
Publication of JP2018512876A publication Critical patent/JP2018512876A/ja
Publication of JP2018512876A6 publication Critical patent/JP2018512876A6/ja
Publication of JP2018512876A5 publication Critical patent/JP2018512876A5/ja
Pending legal-status Critical Current

Links

JP2017555233A 2015-04-22 2016-04-21 saRNA組成物および使用方法 Pending JP2018512876A (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201562150893P 2015-04-22 2015-04-22
US201562150897P 2015-04-22 2015-04-22
US201562150908P 2015-04-22 2015-04-22
US201562150892P 2015-04-22 2015-04-22
US201562150895P 2015-04-22 2015-04-22
US201562150904P 2015-04-22 2015-04-22
US201562150900P 2015-04-22 2015-04-22
US62/150,908 2015-04-22
US62/150,892 2015-04-22
US62/150,893 2015-04-22
US62/150,900 2015-04-22
US62/150,904 2015-04-22
US62/150,897 2015-04-22
US62/150,895 2015-04-22
PCT/GB2016/051116 WO2016170348A2 (en) 2015-04-22 2016-04-21 Sarna compositions and methods of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020162713A Division JP2021035360A (ja) 2015-04-22 2020-08-19 saRNA組成物および使用方法

Publications (3)

Publication Number Publication Date
JP2018512876A JP2018512876A (ja) 2018-05-24
JP2018512876A6 JP2018512876A6 (ja) 2018-10-11
JP2018512876A5 true JP2018512876A5 (enExample) 2019-05-09

Family

ID=56363867

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017555233A Pending JP2018512876A (ja) 2015-04-22 2016-04-21 saRNA組成物および使用方法
JP2020162713A Pending JP2021035360A (ja) 2015-04-22 2020-08-19 saRNA組成物および使用方法
JP2022212928A Pending JP2023040138A (ja) 2015-04-22 2022-12-19 saRNA組成物および使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020162713A Pending JP2021035360A (ja) 2015-04-22 2020-08-19 saRNA組成物および使用方法
JP2022212928A Pending JP2023040138A (ja) 2015-04-22 2022-12-19 saRNA組成物および使用方法

Country Status (4)

Country Link
US (2) US20180305689A1 (enExample)
EP (1) EP3286318A2 (enExample)
JP (3) JP2018512876A (enExample)
WO (1) WO2016170348A2 (enExample)

Families Citing this family (255)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110229471A1 (en) 2008-11-26 2011-09-22 Cedars-Sinai Medical Center Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease
US9828582B2 (en) 2013-03-19 2017-11-28 Duke University Compositions and methods for the induction and tuning of gene expression
KR20240122922A (ko) 2013-03-27 2024-08-13 세다르스-신나이 메디칼 센터 Tl1a 기능 및 관련된 신호전달 경로의 저해에 의한 섬유증 및 염증의 완화 및 반전
EP3022295A4 (en) 2013-07-19 2017-03-01 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
US10676726B2 (en) 2015-02-09 2020-06-09 Duke University Compositions and methods for epigenome editing
US12214054B2 (en) 2015-11-30 2025-02-04 Duke University Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use
US11286533B2 (en) * 2015-12-20 2022-03-29 The National Institute for Biotechnology in the Negev Ltd. Biomarkers of chronic lymphocytic leukemia and use thereof
US11230735B2 (en) * 2015-12-24 2022-01-25 Arizona Board Of Regents On Behalf Of The University Of Arizona Systems and methods for characterizing sepsis
CN108601833B (zh) * 2016-02-01 2022-11-15 伊莱利利公司 甲状旁腺激素-抗rankl抗体融合化合物
CN109462996A (zh) 2016-03-17 2019-03-12 西达-赛奈医疗中心 通过rnaset2诊断炎性肠病的方法
KR102775461B1 (ko) 2016-04-01 2025-02-28 어비디티 바이오사이언시스 인크. 핵산-폴리펩타이드 조성물 및 이의 용도
EP3443081A4 (en) 2016-04-13 2019-10-30 Duke University CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE
KR20230003433A (ko) 2016-05-20 2023-01-05 세다르스-신나이 메디칼 센터 유전자에 기반한 염증성 장 질환의 진단
GB201611738D0 (en) * 2016-07-05 2016-08-17 Cambridge Entpr Ltd Biomarkers for inflammatory bowel disease
JP7490211B2 (ja) 2016-07-19 2024-05-27 デューク ユニバーシティ Cpf1に基づくゲノム編集の治療適用
UY37376A (es) * 2016-08-26 2018-03-23 Amgen Inc Construcciones de arni para inhibir expresión de asgr1 y métodos para su uso
EP3327134A1 (en) * 2016-11-28 2018-05-30 Carsten Korth Method and biomarkers for in vitro diagnosis of mental disorders
CN106834288B (zh) * 2016-12-16 2020-08-21 南京医科大学 一种长非编码rna及其在诊断/治疗胃癌中的应用
KR20240172236A (ko) 2017-01-06 2024-12-09 어비디티 바이오사이언시스 인크. 핵산-폴리펩티드 조성물 및 엑손 스키핑을 유도하는 방법
CN106929508B (zh) * 2017-02-17 2020-08-21 张灏 一种激活PTPRO基因表达的saRNA及其转运载体
EP3635116A1 (en) * 2017-06-08 2020-04-15 Kanduri, Chandrasekhar Long non-coding rna in cancer
GB201709866D0 (en) 2017-06-20 2017-08-02 Immunocore Ltd T cell receptors
US10392616B2 (en) * 2017-06-30 2019-08-27 Arbor Biotechnologies, Inc. CRISPR RNA targeting enzymes and systems and uses thereof
GB201711809D0 (en) 2017-07-21 2017-09-06 Governors Of The Univ Of Alberta Antisense oligonucleotide
WO2019051312A1 (en) * 2017-09-07 2019-03-14 University Of Massachusetts THERAPY AGAINST SELENIUM CANCER
WO2019048645A1 (en) 2017-09-08 2019-03-14 Mina Therapeutics Limited STABILIZED COMPOSITIONS OF SMALL ACTIVATOR RNA (PARNA) FROM CEBPA AND METHODS OF USE
WO2019068099A1 (en) * 2017-09-29 2019-04-04 The Broad Institute, Inc. METHODS AND COMPOSITIONS FOR MODULATION OF LYMPHOCYTE ACTIVITY SUPPRESSION
AU2018374176B2 (en) * 2017-11-30 2024-12-12 Exact Sciences Corporation Detecting breast cancer
PL3717646T3 (pl) * 2017-12-01 2025-10-27 The Texas A&M University System Leczenie antysensowe zespołu angelmana
CN107988223B (zh) * 2017-12-06 2021-08-13 张灏 一种激活PTPRO基因表达的saRNA及其在肿瘤干细胞治疗中的应用
CN118638787A (zh) 2017-12-06 2024-09-13 艾维迪提生物科学公司 治疗肌萎缩和强直性肌营养不良的组合物和方法
EP3720508A4 (en) * 2017-12-08 2021-09-01 University of Connecticut COMPOSITIONS AND METHODS FOR TREATMENT OF GENOMIC FOOTPRINT DISORDERS
CN108130368B (zh) * 2017-12-21 2021-12-14 中国医学科学院北京协和医院 lncRNA在制备诊断或预示青少年特发性脊柱侧凸产品中的应用
CN108085389B (zh) * 2017-12-29 2020-06-09 青岛泱深生物医药有限公司 一种与乳腺癌相关的lncRNA及其应用
CN107937550B (zh) * 2018-01-08 2020-06-02 青岛泱深生物医药有限公司 一种与乳腺癌发生发展相关的生物标志物及其应用
US12509492B2 (en) 2018-01-19 2025-12-30 Duke University Genome engineering with CRISPR-Cas systems in eukaryotes
EP3735248A4 (en) * 2018-02-09 2021-11-17 Empirico Inc. PROCESS FOR INHIBITED OR ELIMINATING EOSINOPHILIC DISEASES OF THE RESPIRATORY TRACT AND ASSOCIATED CONDITIONS
AU2019222767A1 (en) 2018-02-14 2020-08-27 Deep Genomics Incorporated Oligonucleotide therapy for Wilson disease
EP3752616A1 (en) * 2018-02-16 2020-12-23 CRISPR Therapeutics AG Compositions and methods for gene editing by targeting fibrinogen-alpha
WO2019165067A1 (en) 2018-02-21 2019-08-29 Bristol-Myers Squibb Company Camk2d antisense oligonucleotides and uses thereof
CN108192976B (zh) * 2018-03-02 2021-06-04 中南大学湘雅医院 长链非编码rna linc00336作为生物标志物在制备肺鳞癌预后检测制剂中的应用
CN108192975B (zh) * 2018-03-02 2021-06-04 中南大学湘雅医院 长链非编码rna linc00559作为生物标志物在制备肺鳞癌预后检测制剂中的应用
CN108192973B (zh) * 2018-03-02 2021-06-04 中南大学湘雅医院 长链非编码rna linc00559作为生物标志物在制备肺腺癌预后检测制剂中的应用
CN108192974B (zh) * 2018-03-02 2021-11-05 中南大学湘雅医院 长链非编码rna linc00842作为生物标志物在制备肺腺癌预后检测制剂中的应用
CN110959042B (zh) * 2018-04-10 2022-10-18 中美瑞康核酸技术(南通)研究院有限公司 一种新型小激活rna
US11566246B2 (en) * 2018-04-12 2023-01-31 Mina Therapeutics Limited SIRT1-saRNA compositions and methods of use
CN110468200B (zh) * 2018-05-10 2023-02-28 复旦大学附属肿瘤医院 一种用于癌症预后的多基因检测试剂盒
EP3801028A4 (en) 2018-05-30 2022-04-13 Direct Biologics LLC A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
GB2589224A (en) * 2018-06-01 2021-05-26 Childrens Nat Medical Ct Compositions and methods for treating and preventing muscular disorders and dystrophies, steroid side effects, and inflammation
CN108424969B (zh) * 2018-06-06 2022-07-15 深圳市颐康生物科技有限公司 一种生物标志物、诊断或预估死亡风险的方法
CN108753967B (zh) * 2018-06-08 2022-06-17 复旦大学附属中山医院 一种用于肝癌检测的基因集及其panel检测设计方法
EP3813844A1 (en) * 2018-06-28 2021-05-05 United Kingdom Research and Innovation Treatment of cardiomyopathy through modulation of hypoxia-induced erna activity
CN113195738B (zh) * 2018-08-04 2025-01-28 帝国理工学院创新有限公司 识别患有川崎病的受试者的方法
CN109097464B (zh) * 2018-09-19 2021-12-14 中国医学科学院阜外医院深圳医院(深圳市孙逸仙心血管医院) Cfap43基因的snp位点的应用
CN109097465B (zh) * 2018-09-19 2021-06-08 蒲佐 Clip3基因的snp位点的应用
CN115044667A (zh) * 2018-09-21 2022-09-13 王赞鑫 与主动脉夹层疾病相关的snp位点及其应用
WO2020061591A1 (en) * 2018-09-21 2020-03-26 President And Fellows Of Harvard College Methods and compositions for treating diabetes, and methods for enriching mrna coding for secreted proteins
WO2020069373A1 (en) 2018-09-28 2020-04-02 President And Fellows Of Harvard College Cellular reprogramming to reverse aging and promote organ and tissue regeneration
US12274733B2 (en) 2018-09-28 2025-04-15 President And Fellows Of Harvard College Cellular reprogramming to reverse aging and promote organ and tissue regeneration
WO2020069339A1 (en) 2018-09-28 2020-04-02 President And Fellows Of Harvard College Mutant reverse tetracycline transactivators for expression of genes
CN109182503B (zh) * 2018-09-28 2021-09-28 新乡医学院 动脉粥样硬化分子标志物及其应用
CN111020029B (zh) * 2018-10-10 2023-09-29 江苏普瑞悉恩生物科技有限公司 实时荧光定量pcr检测pd-l1基因表达量的方法、引物及试剂盒
EP3847281A4 (en) * 2018-10-25 2022-04-27 Quadrant Biosciences Inc. METHODS AND MACHINE LEARNING FOR DISEASE DIAGNOSIS
CN113167782B (zh) * 2018-10-30 2025-07-11 私募蛋白质体操作有限公司 用于样品质量评估的方法
CN109207585A (zh) * 2018-11-01 2019-01-15 中国人民解放军第Oo医院 免疫性血小板减少症lncRNA标志物及试剂盒和应用
WO2020097414A1 (en) 2018-11-08 2020-05-14 Greenlight Biosciences, Inc. Control of insect infestation
CN109207598A (zh) * 2018-11-09 2019-01-15 汕头大学医学院附属肿瘤医院 一种长链非编码rna在制备食管癌诊断试剂或治疗药物中的应用
EP3881233A4 (en) * 2018-11-15 2022-11-23 Ampel Biosolutions, LLC DISEASE PREDICTION AND TREATMENT PRIORIZATION WITH MACHINE LEARNING
US12548678B2 (en) 2020-05-14 2026-02-10 Ampel Biosolutions, Llc Methods and systems for machine learning analysis of single nucleotide polymorphisms in lupus
EP3894559A4 (en) * 2018-12-03 2023-04-05 Triplet Therapeutics, Inc. METHODS OF TREATMENT OF TRINUCLEOTIDE REPEAT EXPANSION DISORDERS RELATED TO MLH3 ACTIVITY
US20220056444A1 (en) * 2018-12-05 2022-02-24 Empirico Inc. Process to inhibit or eliminate eosinophilic diseases of the airway and related conditions
CN110093348B (zh) * 2018-12-05 2022-11-29 西北工业大学 增强小鼠NPFFR2基因表达的shRNA
CN109355391A (zh) * 2018-12-05 2019-02-19 山东省千佛山医院 Linc01876作为诊断肝癌的分子标志物的应用
CN113227375A (zh) 2018-12-20 2021-08-06 原住民股份有限公司 合成的微小rna模拟物
IL312067B2 (en) 2018-12-21 2025-08-01 Avidity Biosciences Inc Anti-transferrin receptor antibodies and uses thereof
MX2021007932A (es) * 2018-12-29 2021-08-16 Ractigen Therapeutics Molecula oligomerica de acido nucleico y uso de esta.
CN109813912B (zh) * 2019-01-04 2021-12-28 深圳大学 一组血清差异蛋白组合在制备用于检测孤独症的试剂中的应用
CN109837336B (zh) * 2019-01-09 2022-07-19 中国人民解放军军事科学院军事医学研究院 辐射敏感基因标记物及在鉴别高let射线辐射中的应用
CN109652532A (zh) * 2019-01-11 2019-04-19 中国人民解放军总医院 一种检测心血管系统用药的标志物
EP3911957A1 (en) * 2019-01-17 2021-11-24 F. Hoffmann-La Roche AG E3 ubiquitin ligase (ube3a) protein targets
US20220062379A1 (en) * 2019-01-18 2022-03-03 The General Hospital Corporation Methods and compositions for modulating immune dysregulation
KR102162847B1 (ko) * 2019-01-23 2020-10-07 차의과학대학교 산학협력단 요로결석 진단을 위한 분석방법 및 키트
JP2022518916A (ja) * 2019-01-24 2022-03-17 ラクティゲン セラピューティクス スキンケア用のオリゴ核酸
CN118546926A (zh) * 2019-01-30 2024-08-27 中美瑞康核酸技术(南通)研究院有限公司 寡核苷酸分子及其在肿瘤治疗中的应用
IL320107A (en) 2019-02-07 2025-06-01 Direct Biologics Llc Method for treating osteoarthritis with a combination of mesenchymal stem cell exosomes, synovial mesencymal stem cells, and scaffolds
US20220290122A1 (en) * 2019-02-19 2022-09-15 Whitehead Institute For Biomedical Research Methods and agents for modulating mitochondrial nad levels
MY207814A (en) * 2019-03-07 2025-03-20 Reti Mark Co Ltd Combination of biomarkers for diagnosing of diabetic retinopathy and use thereof
CA3162618A1 (en) 2019-03-20 2020-09-24 Peter Jungsoo PARK Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases
KR20200113556A (ko) * 2019-03-25 2020-10-07 황인후 St8sia1를 이용한 당뇨병의 예방 또는 치료용 조성물과 당뇨병 치료제 스크리닝 방법
BR112021018823A2 (pt) * 2019-03-25 2021-11-23 Univ Leland Stanford Junior Assinatura para diagnóstico de infecções bacterianas vs virais
CN109880828B (zh) * 2019-03-26 2021-02-05 河南师范大学 干扰Mroh7基因表达的siRNA及其应用、干扰方法与药物
CN114450411A (zh) 2019-04-01 2022-05-06 特纳亚治疗股份有限公司 具有工程化衣壳的腺相关病毒
TWI887234B (zh) 2019-04-14 2025-06-21 美國公爵大學 治療杜興氏(duchenne)肌肉失養症之大型突變熱點之aav載體介導之刪除
US20220175816A1 (en) * 2019-04-18 2022-06-09 University Of Massachusetts Aim2 inhibitors and uses thereof
WO2020219820A1 (en) 2019-04-25 2020-10-29 Avidity Biosciences, Inc. Nucleic acid compositions and methods of multi-exon skipping
CN111849968A (zh) 2019-04-30 2020-10-30 中美瑞康核酸技术(南通)研究院有限公司 寡核苷酸分子及其在急性间歇性卟啉症治疗中的应用
US20220228146A1 (en) * 2019-05-06 2022-07-21 The Children's Hospital Of Philadelphia Micro-rna site blocking oligonucleotides for the treatment of epileptic encephalopathy and neurodevelopmental disorders
US20220265862A1 (en) * 2019-05-09 2022-08-25 The Children's Hospital Of Philadelphia Compositions and methods for the treatment of leukodystrophy and whole animal and cellular models for identifying efficacious agents for treatment of the same
CN110079601B (zh) * 2019-05-23 2022-04-19 青岛市中心医院 放射性相关疾病诊疗标志物及其应用
CN110106180B (zh) * 2019-05-29 2020-10-16 中国医科大学附属盛京医院 一种lncRNA分子及其在胶质瘤治疗/预后评估中的应用
GB201907882D0 (en) 2019-06-03 2019-07-17 Cyprus Foundation For Muscular Dystrophy Res Methods
CN110117659B (zh) * 2019-06-18 2022-10-11 上海奕谱生物科技有限公司 一种新型的肿瘤标记物stamp-ep10及其应用
CN110184358A (zh) * 2019-06-25 2019-08-30 台州市立医院 甲状腺癌早期诊断用的oit3基因及其应用
EP3990119A4 (en) * 2019-06-26 2024-03-27 Fred Hutchinson Cancer Center METHODS AND COMPOSITIONS COMPRISING BRD9 ACTIVATION THERAPIES FOR THE TREATMENT OF CANCERS AND RELATED DISORDERS
WO2021011935A1 (en) 2019-07-18 2021-01-21 Direct Biologics, Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
CN110577988B (zh) * 2019-07-19 2022-12-20 南方医科大学 胎儿生长受限的预测模型
CN110456060B (zh) * 2019-07-31 2022-09-09 四川大学华西医院 Efcab13自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
WO2021030522A1 (en) * 2019-08-13 2021-02-18 Alnylam Pharmaceuticals, Inc. SMALL RIBOSOMAL PROTEIN SUBUNIT 25 (RPS25) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
CN114585633A (zh) 2019-08-19 2022-06-03 米纳治疗有限公司 寡核苷酸缀合物组合物和使用方法
CN110541027A (zh) * 2019-08-21 2019-12-06 昆明医科大学第一附属医院 lncRNA HIF1A-AS1抗深静脉血栓的应用
CN112444627B (zh) * 2019-09-05 2022-03-29 四川大学华西医院 一种高危胸痛筛查试剂盒
CA3148158A1 (en) * 2019-09-20 2021-03-25 Longcheng Li Nucleic acid molecule for treating thrombocytopenia and use thereof
EP4055175A4 (en) 2019-11-04 2023-11-29 Decibel Therapeutics, Inc. Cochlear inner hair cell promoters and uses thereof
JP2023501352A (ja) * 2019-11-08 2023-01-18 アイオーニス ファーマシューティカルズ, インコーポレーテッド Spdef発現を低減するための化合物及び方法
CN110876752B (zh) * 2019-11-18 2021-04-30 暨南大学 长链非编码rna nron功能基序在制备抑制骨吸收及防治骨质疏松药物中的应用
WO2021113805A1 (en) * 2019-12-05 2021-06-10 The General Hospital Corporation Multi-biomarker prediction models for multiple infection episodes following blunt trauma
CN111197073A (zh) * 2019-12-19 2020-05-26 武汉艾米森生命科技有限公司 从粪便中提取dna样本的方法和结直肠癌相关基因的甲基化检测方法
CN112795579B (zh) * 2019-12-25 2022-03-18 四川省人民医院 克山病基因筛查试剂盒
CN113092774B (zh) * 2020-01-09 2022-08-19 中国科学院生物物理研究所 mtEF4蛋白作为毛发生长和脱发的生物标志物的用途
CN111118154B (zh) * 2020-01-16 2022-10-18 华南协同创新研究院 Linc01272在制备肿瘤检测试剂和/或治疗药物中的应用
CN113134010B (zh) * 2020-01-20 2023-09-01 上海市生物医药技术研究院 一种靶向雌激素受体α的微小RNA及其抗肿瘤用途
US12551528B2 (en) * 2020-01-24 2026-02-17 Arizona Board Of Regents On Behalf Of The University Of Arizona Compounds and methods for treating or reducing pruritus
EP3865591B1 (en) * 2020-02-14 2024-04-03 Cardiomix S.r.l. Set of biomarkers for the diagnosis of brugada syndrome
CN111214482B (zh) * 2020-02-21 2022-11-11 东莞市第八人民医院(东莞市儿童医院) 一种靶向linc00467基因的siRNA在白血病耐药性中的应用
CN111254193A (zh) * 2020-02-27 2020-06-09 上海交通大学 Dna甲基化标志物pcyt1a在制备诊断pcos试剂盒中的应用
CN111440867B (zh) * 2020-03-06 2020-12-22 河北医科大学第二医院 生物标志物在肝癌诊断和治疗中的应用
CN111394351B (zh) * 2020-03-18 2023-11-07 济南爱新卓尔医学检验有限公司 一种抑制DICER1-AS1表达的siRNA及其应用
TW202144572A (zh) 2020-03-19 2021-12-01 美商亞維代堤生物科學公司 治療臉肩胛肱骨肌肉失養症之組合物及方法
KR102927945B1 (ko) 2020-03-27 2026-02-23 어비디티 바이오사이언시스 인크. 근이영양증의 치료용 조성물 및 방법
CN116096890A (zh) 2020-04-02 2023-05-09 米雷楚莱股份有限公司 使用工程化寡核苷酸的靶向抑制
CN111424091B (zh) * 2020-04-20 2022-02-08 中国医学科学院北京协和医院 一组鉴别诊断甲状腺滤泡性肿瘤良恶性的标志物及其应用
MX2022013301A (es) 2020-04-22 2023-02-14 Direct Biologics Llc Métodos y composiciones para tratar las afecciones inflamatorias asociadas con una enfermedad infecciosa.
CN111458510B (zh) * 2020-04-30 2020-10-30 郑州大学第一附属医院 一组早期食管癌和高危人群筛查标志物及相关联检卡
EP4153995A4 (en) * 2020-05-19 2024-10-23 Falcon Bioscience, LLC DETECTION AND TREATMENT OF CONDITIONS CHARACTERIZED BY PERFUSION ENGAGEMENT
CN111562394B (zh) * 2020-06-02 2021-07-02 西安交通大学医学院第一附属医院 热休克因子2结合蛋白在肝脏缺血再灌注损伤、药物性肝损伤中的应用
JP2023529398A (ja) * 2020-06-10 2023-07-10 ラクティゲン セラピューティクス Mitf遺伝子を標的とする核酸分子及びその使用
WO2021258011A1 (en) * 2020-06-19 2021-12-23 Ionis Pharmaceuticals, Inc. Compounds and methods for modulating pmp22
CN111718956B (zh) * 2020-06-30 2022-11-04 山东农业大学 一种鸡源trim25基因重组荧光表达质粒的制备方法和应用
CN111593127A (zh) * 2020-06-30 2020-08-28 北京泱深生物信息技术有限公司 与喉鳞癌密切相关的非编码rna
CN111910000B (zh) * 2020-07-02 2022-07-01 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 一种预测鼻咽癌预后的肿瘤微环境成分标志物组合及系统
CN111778562A (zh) * 2020-07-08 2020-10-16 复旦大学附属华山医院 一种用于获取颅颈动脉夹层致病基因突变相关信息的dna文库及应用
CN112063707B (zh) * 2020-07-09 2022-04-22 浙江大学 长链非编码rna loc102724238在诊断和治疗原发性翼状胬肉中的应用
CN113930423B (zh) * 2020-07-14 2024-05-10 北京大学 保护心肌细胞免受应激损伤的saRNA及其应用
WO2022015998A1 (en) * 2020-07-15 2022-01-20 University Of Connecticut Gene panels and methods of use thereof for screening and diagnosis of congenital heart defects and diseases
CN111733249B (zh) * 2020-07-21 2020-12-11 北京泱深生物信息技术有限公司 喉癌发生发展相关分子标志物
IL300287A (en) * 2020-07-31 2023-04-01 Ractigen Therapeutics Combined treatment of SMA with SARNA and mRNA modulators
KR20230048080A (ko) * 2020-08-03 2023-04-10 카스마 테라퓨틱스, 인코포레이티드 Tfeb 활성화 및 리소좀의 생물발생 방법 및 이를 위한 조성물
WO2022035984A1 (en) * 2020-08-12 2022-02-17 Skyhawk Therapeutics, Inc. Antisense oligonucleotides for treatment of conditions and diseases related to trem2
CN112094896B (zh) * 2020-08-27 2024-02-09 上海市公共卫生临床中心 活动性结核病诊断标志物、试剂盒及其应用
AU2021342155A1 (en) 2020-09-11 2023-04-13 Arrowhead Pharmaceuticals, Inc. RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use
US20230372542A1 (en) * 2020-09-30 2023-11-23 The Regents Of The University Of California Composition and methods for modulating tcf4 gene expession and treating pitt hopkins syndrome
JP7415042B2 (ja) 2020-10-09 2024-01-16 テナヤ セラピューティクス, インコーポレイテッド プラコフィリン2遺伝子治療の方法および組成物
CN112143813B (zh) * 2020-10-28 2021-06-29 镇江市第一人民医院 Prr34-as1作为新型分子标志物及其定量检测方法和应用
KR20230100729A (ko) * 2020-10-30 2023-07-05 푸단 유니버시티 면역반응 조절 또는 항종양 약물 제조에 있어 itpripl1 조절제의 용도
CN112575076A (zh) * 2020-11-02 2021-03-30 深圳恒生医院 一种用于检测和评估早期自然流产的LncRNA标记物及应用其的产品
WO2022100748A1 (en) * 2020-11-16 2022-05-19 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Recombinant adeno-associated viruses with enhanced liver tropism and uses thereof
CN112251513B (zh) * 2020-11-26 2023-02-17 中国人民解放军总医院第一医学中心 一种食管癌和/或胃癌分子标志物Lnc5q31.1、引物、试剂盒及应用
CN112553199A (zh) * 2020-11-30 2021-03-26 深圳市人民医院 一种snhg17-KO基因敲除小鼠模型的构建方法和应用
CN112553333B (zh) * 2020-12-08 2022-03-08 南方医科大学深圳医院 miR-1207及其靶基因在检测喉鳞癌中的应用
US20240392297A1 (en) * 2020-12-23 2024-11-28 Eli Lilly And Company Rna therapeutics and methods of use thereof
CN112661826B (zh) * 2020-12-25 2022-03-29 中山大学 小肽ERpeptide及其在急性髓系白血病中的应用
CN112641797B (zh) * 2020-12-30 2021-12-17 温州医科大学 抑制结直肠癌生长、转移的靶标与诊断标志物及其应用
CA3204918A1 (en) * 2021-01-14 2022-07-21 Chi T. VIET Methods for evaluation of early stage oral squamous cell carcinoma
CN112725450B (zh) * 2021-01-27 2022-06-10 青岛市妇女儿童医院 一种用于治疗口腔鳞状细胞癌的药物
CN112941076B (zh) * 2021-02-05 2023-07-07 中国药科大学 FXR靶向的saRNA及其应用
CN112961914B (zh) * 2021-02-07 2022-08-30 安徽省立医院(中国科学技术大学附属第一医院) miR-3074-5p作为类风湿关节炎标志物的应用及其试剂盒
WO2022166849A1 (en) * 2021-02-08 2022-08-11 Ractigen Therapeutics Multi-valent oligonucleotide agent and methods of use thereof
GB2603935B (en) * 2021-02-19 2023-11-01 Micrographia Bio Ltd Method and kits for multiplex fluorescent microscopy
CN112725471B (zh) * 2021-03-12 2022-09-16 中国大熊猫保护研究中心 野化培训大熊猫免疫适应的分子标记评估方法
US20240175033A1 (en) * 2021-03-26 2024-05-30 Mina Therapeutics Limited TMEM173 saRNA Compositions and Methods of Use
WO2022212208A1 (en) * 2021-03-29 2022-10-06 University Of Massachusetts Oligonucleotides for syngr-3 modulation
WO2022215066A1 (en) * 2021-04-05 2022-10-13 Itayandbiond Ltd Small activating rna increasing shank expression and method of treating intellectual disabilities and associated comorbidities associated with shank haploinsufficiency
WO2022214635A1 (en) * 2021-04-08 2022-10-13 Stichting Vu Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders
CA3214688A1 (en) 2021-04-08 2022-10-13 Andrzej KROLEWSKI Methods of diagnosing and predicting renal decline
US20240218454A1 (en) * 2021-04-22 2024-07-04 H. Lee Moffitt Cancer Center And Research Institute, Inc. Diagnostic to support clinical trial matching and exploratory biomarker analyses in cancer patients
WO2022226267A1 (en) * 2021-04-23 2022-10-27 Alnylam Pharmaceuticals, Inc. iRNA COMPOSITIONS AND METHODS FOR SILENCING CHITINASE 3-LIKE PROTEIN 1/YKL-40 (CHI3L1/YKL-40) PROTEIN
CN112921098B (zh) * 2021-04-27 2023-05-05 深圳市人民医院 一种用于三阴性乳腺癌检测的标志物及其检测试剂和应用
CN113151471B (zh) * 2021-04-28 2022-08-12 复旦大学附属中山医院 用于检测肺腺癌kras突变的基因组合物、试剂盒和方法
US20240417737A1 (en) * 2021-05-17 2024-12-19 Uniqure France Methods and compositions for treating epilepsy
CN113234834A (zh) * 2021-07-09 2021-08-10 北京泱深生物信息技术有限公司 一组用于胰腺癌预后的基因及其应用
WO2023020980A1 (en) * 2021-08-16 2023-02-23 F. Hoffmann-La Roche Ag E3 ubiquitin ligase (ube3a) protein targets
CN113430273B (zh) * 2021-08-17 2022-05-27 广州齐凯生物科技有限公司 长链非编码rna linc01565在急性髓系白血病预后中的应用
CN113925975B (zh) * 2021-08-31 2024-05-28 杭州师范大学 p53及UTX信使RNA纳米粒的制备方法及该信使RNA的应用
EP4402279A4 (en) * 2021-09-16 2025-07-23 Icahn School Med Mount Sinai METHODS OF TREATMENT AND DIAGNOSIS OF THE RISK OF FIBROSIS AND RENAL ALLOGRAFT REJECTION
EP4401792A4 (en) 2021-09-16 2025-12-03 Avidity Biosciences Inc COMPOSITIONS AND METHODS OF TREATMENT OF FACIO-SCAPULO-HUMERAL MUSCULAR DYSTROPHY
WO2023064604A1 (en) * 2021-10-14 2023-04-20 New York Stem Cell Foundation, Inc. Modified cells and methods of use thereof
KR102711436B1 (ko) * 2021-10-26 2024-09-26 사회복지법인 삼성생명공익재단 대장암의 치료 및 전이 억제용 조성물 및 이의 용도
US20260055415A1 (en) * 2021-10-28 2026-02-26 Baylor College Of Medicine Targeting neuronal sirpa for treatment and prevention of neurological disorders
EP4427043A4 (en) * 2021-11-05 2026-02-11 Univ Johns Hopkins USE OF BIOMARKERS IN THE DIAGNOSIS AND TREATMENT OF LUPUS NEPHROPATHY
CN114134147B (zh) * 2021-11-16 2023-11-14 山东大学 一种调控fzd9的非编码rna及其应用
CN114214322A (zh) * 2021-11-23 2022-03-22 中国辐射防护研究院 LincR-0003及其作为辐射损伤早期诊断的分子标志物的用途
CN118541484A (zh) * 2021-12-17 2024-08-23 豪夫迈·罗氏有限公司 反义寡核苷酸
KR20240123838A (ko) * 2021-12-20 2024-08-14 프라이 유니베르시탯 베를린 Rbm3 발현을 증가시키는 방법 및 제제
CN114196675A (zh) * 2021-12-24 2022-03-18 复旦大学附属肿瘤医院 靶向linc00624的反义寡核苷酸及其在乳腺癌治疗中的应用
CN114288315B (zh) * 2022-01-13 2022-08-16 暨南大学附属第一医院(广州华侨医院) 一种包含ccp110抑制剂的药物组合物及其应用
CN116486918B (zh) * 2022-01-14 2026-03-24 天士力干细胞产业平台有限公司 一种干细胞质量评价方法
CN115247176B (zh) * 2022-01-17 2023-06-20 郑州大学第一附属医院 一种长链非编码rna及其应用
CN114540500A (zh) * 2022-03-21 2022-05-27 深圳市陆为生物技术有限公司 评价乳腺癌患者整体生存的产品
KR20240165951A (ko) * 2022-03-23 2024-11-25 피와이씨 테라퓨틱스 리미티드 녹내장 치료 방법
CN114774445B (zh) * 2022-03-29 2024-01-02 中国人民解放军西部战区总医院 一种dynlt5基因在动脉粥样斑及组织修复中的应用
EP4499122A4 (en) * 2022-03-29 2026-07-01 Direct Biologics Llc RNA COMPRISING SECRETOMES AND THEIR METHODS OF USE
WO2023191957A1 (en) * 2022-03-30 2023-10-05 Mirimus, Inc. Compositions and methods of generating novel amirna
CN114574493A (zh) * 2022-04-02 2022-06-03 中国科学院遗传与发育生物学研究所 一种编辑绵羊SOCS2基因的sgRNA组合、扩增用引物和应用
US12071621B2 (en) 2022-04-05 2024-08-27 Avidity Biosciences, Inc. Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
US20260043030A1 (en) * 2022-04-08 2026-02-12 Secarna Pharmaceuticals Gmbh & Co. Kg Oligonucleotide for reducing the expression of leucine-rich repeat kinase 2 (LRRK2) and its use for preventing and/or treating human diseases
US20250263681A1 (en) * 2022-04-12 2025-08-21 Orthobio Therapeutics, Inc. Lipid nanoparticles for gene editing systems
IT202200011546A1 (it) * 2022-06-01 2022-09-01 Univ Degli Studi Di Trento Sequenze di RNA non codificanti in grado di aumentare l'espressione delle proteine CHD8 e CHD2
CN114959041B (zh) * 2022-06-19 2023-08-22 瓯江实验室 抑制结直肠癌增殖转移的新靶标与诊断标志物及其应用
CN119654412A (zh) * 2022-06-27 2025-03-18 中美瑞康核酸技术(南通)研究院有限公司 激活补体因子h表达的寡核苷酸调节剂
JPWO2024005158A1 (enExample) * 2022-06-30 2024-01-04
WO2024006994A2 (en) * 2022-07-01 2024-01-04 The University Of Chicago Compositions and methods for the treatment of cancer by targeting the brca1 pseudogene 1 (brca1p1)
TW202403054A (zh) * 2022-07-04 2024-01-16 大陸商江蘇鵾遠生物科技股份有限公司 癌症特異性甲基化標誌物及其應用
CN115725587B (zh) * 2022-09-14 2023-07-18 中国人民解放军军事科学院军事医学研究院 一组特异性识别辐射敏感蛋白tp53i3的寡核苷酸适配体及试剂盒和检测方法
CN116103287B (zh) * 2022-09-19 2025-02-14 南通市肿瘤医院 一种抑制GRWD1基因的siRNA分子及其应用
CN116121247B (zh) * 2022-09-26 2025-11-11 青岛大学 促进ABCG2基因表达的saRNA及其应用
EP4599060A1 (en) * 2022-10-06 2025-08-13 Stichting Radboud universitair medisch centrum Antisense oligonucleotides for treatment of usher 2a. exons 30-31
EP4599061A1 (en) * 2022-10-06 2025-08-13 Stichting Radboud universitair medisch centrum Antisense oligonucleotides for treatment of usher 2a. exon 68
WO2024110770A1 (en) * 2022-11-22 2024-05-30 INSERM (Institut National de la Santé et de la Recherche Médicale) A new promoter for retinal pigment epithelium (rpe) targeted gene therapy
JP2026504730A (ja) 2022-12-15 2026-02-09 エンピリコ インク. Mst1関連の疾患および障害の処置
US20260218178A1 (en) 2022-12-22 2026-07-30 Mina Therapeutics Limited Chemically Modified saRNA Compositions and Methods of Use
US12252518B2 (en) 2023-01-06 2025-03-18 Life Biosciences, Inc. Methods of treating non-arteritic anterior ischemic optic neuropathy
WO2024163651A2 (en) * 2023-01-31 2024-08-08 AcuraStem Incorporated Syf2 antisense oligonucleotides
CN115948561B (zh) * 2023-02-10 2024-01-02 武汉艾米森生命科技有限公司 一种用于食管鳞癌诊断或辅助诊断的试剂、检测试剂盒及其应用
JP2026509436A (ja) * 2023-03-06 2026-03-19 ラクティゲン セラピューティクス 第vii因子発現を活性化するオリゴヌクレオチド調節因子およびその血友病治療への使用
CN116173058B (zh) * 2023-03-08 2025-03-14 天津医科大学第二医院 一种bp-pei@rna纳米药物复合体、制备方法及其在治疗癌症中的应用
EP4689117A1 (en) * 2023-03-31 2026-02-11 The Board of Trustees of the Leland Stanford Junior University Therapeutic strategy for pcdh19-related encephalopathy
EP4695397A1 (en) * 2023-04-14 2026-02-18 Avicenna Biotech Research, Llc Rna-based compositions and methods for treating breast cancer
WO2024229292A2 (en) * 2023-05-02 2024-11-07 Duke University Compositions and methods for engineering mature ipsc-derived and esc-derived hepatocytes
CN117165672B (zh) * 2023-08-31 2025-04-01 重庆医科大学 Mov10作为新靶点在糖尿病肾病诊断和治疗药物中的应用
EP4539816A4 (en) * 2023-09-01 2025-07-23 Follea Int COMPOSITIONS AND METHODS FOR AN ORALLY ADMINISTERED MINOXIDIL SUPPLEMENT FOR THE TREATMENT OF ALOPECIA
KR20250064736A (ko) * 2023-11-02 2025-05-12 (주)지노믹트리 방광암 예방 또는 치료용 조성물
WO2025101979A1 (en) * 2023-11-08 2025-05-15 Nchroma Bio, Inc. Compositions and methods for epigenetic regulation of genes for treatment of non-alcoholic steatohepatitis or metabolic dysfunction-associated steatohepatitis
WO2025111565A1 (en) * 2023-11-22 2025-05-30 Empirico Inc. Treatment of sos2 related diseases and disorders
WO2025155773A1 (en) * 2024-01-19 2025-07-24 Gene Company (Pty)Ltd. Telomerase upregulating polynucleotide and method of use and treatment thereof
WO2025159427A1 (ko) * 2024-01-26 2025-07-31 서울대학교산학협력단 신규한 apoe 안티센스 올리고뉴클레오타이드 및 이의 용도
WO2025165891A1 (en) 2024-01-29 2025-08-07 Arnatar Therapeutics, Inc Translation enhancing nucleic acid compounds: aso coupled translation - upregulation 1 (act-up1) and uses thereof
WO2025171086A1 (en) * 2024-02-07 2025-08-14 Asimov Inc. Promoters and uses thereof
US12417220B2 (en) * 2024-02-22 2025-09-16 Sap Se Generative data modeling using large language model
WO2025207750A1 (en) * 2024-03-26 2025-10-02 N-Lorem Foundation Kif1a-targeted oligomeric compounds and uses thereof
WO2025207784A1 (en) * 2024-03-26 2025-10-02 The Children's Medical Center Corporation Slc6a1 gene therapy constructs
WO2025222056A1 (en) * 2024-04-19 2025-10-23 Empirico Inc. Treatment of cdhr3 related diseases and disorders
WO2025224036A1 (en) 2024-04-22 2025-10-30 Mina Therapeutics Limited Chemically modified sarna compositions and methods of use
WO2025226276A1 (en) 2024-04-25 2025-10-30 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles
WO2025231449A1 (en) * 2024-05-02 2025-11-06 Institute For Myeloma & Bone Cancer Research Prediction, diagnosis, and treatment of multiple myeloma
WO2025231528A1 (en) * 2024-05-09 2025-11-13 Baker Heart and Diabetes Institute Compositions and methods for treating fibrosis
WO2025240499A1 (en) * 2024-05-15 2025-11-20 Empirico Inc. Treatment of plod2 related diseases and disorders
CN118717788A (zh) * 2024-07-10 2024-10-01 广东医科大学附属医院 一种lncRNA在制备结肠癌药物中的应用
WO2026027887A2 (en) * 2024-08-02 2026-02-05 Mina Therapeutics Limited Hbg1/2-sarna compositions and methods of use
WO2026107335A1 (en) * 2024-11-14 2026-05-21 University Of Utah Research Foundation Compositions and methods for treating hepatic diseases by inhibiting efhd1
CN119780433B (zh) * 2024-12-13 2025-07-29 首都医科大学附属北京友谊医院 一种以otud7b为靶点在制备诊断和/或防治主动脉夹层产品中的应用
WO2026124614A1 (en) * 2024-12-13 2026-06-18 Nitrase Therapeutics, Inc. Methods of treating disorders
CN121249659A (zh) * 2025-04-07 2026-01-02 首都医科大学附属北京儿童医院 一种靶向PRMT3抑制HIV-1复制、转录再激活的siRNA
CN120771286A (zh) * 2025-07-18 2025-10-14 首都医科大学宣武医院 Nsun3在促进周围神经损伤修复中的应用
CN121518581A (zh) * 2025-12-08 2026-02-13 江苏农牧科技职业学院 Prtfdc1基因在促进猪骨骼肌卫星细胞分化、肌管形成与骨骼肌生长发育中的应用
CN121668182A (zh) * 2026-02-05 2026-03-17 南通大学 小分子药物saEml1及其在脊髓损伤修复中的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1255550A (zh) * 1998-11-30 2000-06-07 张良平 一种新的抗异种移植抗原位点合成酶反义基因克隆
EP2305813A3 (en) * 2002-11-14 2012-03-28 Dharmacon, Inc. Fuctional and hyperfunctional sirna
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
WO2004070062A2 (en) * 2003-02-04 2004-08-19 Wyeth Compositions and methods for diagnosing and treating cancers
JP5362350B2 (ja) * 2005-04-15 2013-12-11 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 小分子活性化rna分子及び使用方法
JP5141256B2 (ja) 2005-10-20 2013-02-13 旭硝子株式会社 ポリテトラフルオロエチレン水性分散液およびその製品
CA2629664A1 (en) 2005-11-17 2007-08-02 Board Of Regents, The University Of Texas System Modulation of gene expression by oligomers targeted to chromosomal dna
CN103301475B (zh) 2005-12-28 2016-08-03 斯克里普斯研究所 药物组合物和表达载体以及调节基因表达的方法和核酸分子的应用
US8178503B2 (en) * 2006-03-03 2012-05-15 International Business Machines Corporation Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
US7901882B2 (en) * 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
EP2515947B1 (en) * 2009-12-23 2021-10-06 CuRNA, Inc. Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
GB201010557D0 (en) * 2010-06-23 2010-08-11 Mina Therapeutics Ltd RNA molecules and uses thereof
CA2817191A1 (en) * 2010-10-08 2012-04-12 Pal Saetrom Short rna molecules
EP3702460A1 (en) 2010-11-12 2020-09-02 The General Hospital Corporation Polycomb-associated non-coding rnas
WO2012088443A1 (en) * 2010-12-24 2012-06-28 Kevadiya, Inc. System and method for automated capture and compaction of instructional performances
US11293064B2 (en) * 2013-05-02 2022-04-05 Thomas Jefferson University Human miRNAs for use in diagnosis, prognosis, and therapy of human conditions and diseases
WO2023099884A1 (en) * 2021-12-01 2023-06-08 Mina Therapeutics Limited Pax6 sarna compositions and methods of use

Similar Documents

Publication Publication Date Title
JP2023040138A5 (enExample)
HRP20210612T1 (hr) Postupci i pripravci za specifičnu inhibiciju glikolat oksidaze (hao1) pomoću dvolančane rnk
JP2015518712A5 (enExample)
EP4455285A3 (en) Nucleic acid, composition and conjugate comprising the same, and preparation method and use thereof
JP2015523853A5 (enExample)
JP2015518710A5 (enExample)
JP2016522674A5 (enExample)
JP2015519057A5 (enExample)
JP2015518714A5 (enExample)
JP2015518711A5 (enExample)
JP2015523855A5 (enExample)
JP2015518713A5 (enExample)
JP2018519835A5 (enExample)
HRP20201200T1 (hr) OLIGONUKLEOTIDNI SPOJEVI ZA CILJANJE HUNTINGTIN mRNK
HK1221978A1 (zh) Tmprss6 irna组合物及其使用方法
JP2015511821A5 (enExample)
JP2013532952A5 (enExample)
JP2016521556A5 (enExample)
JP2017093448A5 (enExample)
MX2024005653A (es) Agentes de acido ribonucleico (arn) de cadena doble modificados.
JP2018513668A5 (enExample)
PH12013500374A1 (en) Heavy metal reduction in planta
JP2014527401A5 (enExample)
WO2016106401A3 (en) Rna agents for p21 gene modulation
JP2013226147A5 (enExample)